Scarica l'app Stockscreener
7.505
1.90%
0.145
Precedente Chiudi:
$7.36
Aprire:
$7.38
Volume 24 ore:
85,295
Relative Volume:
0.03
Capitalizzazione di mercato:
$590.13M
Reddito:
$65,400
Utile/perdita netta:
$-46.34M
Rapporto P/E:
-8.1576
EPS:
-0.92
Flusso di cassa netto:
$-38.74M
1 W Prestazione:
-2.47%
1M Prestazione:
+6.23%
6M Prestazione:
-37.91%
1 anno Prestazione:
-28.16%
Intervallo 1D:
$7.38
$7.57
Intervallo di 1 settimana:
$7.29
$7.85
Portata 52W:
$5.60
$17.43
CorMedix Inc Stock (CRMD) Company Profile
Nome
CorMedix Inc
Settore
Industria
Telefono
908-517-9500
Indirizzo
400 Connell Drive, 5th Floor, Suite 5000, Berkeley Heights, NJ
Compare CRMD vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CRMD
CorMedix Inc
|
7.49 | 579.89M | 65,400 | -46.34M | -38.74M | -0.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.25 | 117.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
797.54 | 82.85B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
840.19 | 51.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
309.63 | 40.75B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
350.58 | 38.33B | 4.98B | 69.60M | 525.67M | 0.5198 |
CorMedix Inc Stock (CRMD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-20 | Aggiornamento | D. Boral Capital | Hold → Buy |
| 2025-06-30 | Downgrade | D. Boral Capital | Buy → Hold |
| 2025-06-30 | Iniziato | H.C. Wainwright | Buy |
| 2025-03-07 | Iniziato | Leerink Partners | Outperform |
| 2025-01-13 | Iniziato | D. Boral Capital | Buy |
| 2024-08-26 | Iniziato | Rodman & Renshaw | Buy |
| 2023-08-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-02-17 | Iniziato | Needham | Buy |
| 2020-09-29 | Iniziato | JMP Securities | Mkt Outperform |
| 2020-09-21 | Iniziato | Truist | Buy |
| 2019-12-18 | Iniziato | B. Riley FBR | Buy |
| 2019-03-26 | Reiterato | H.C. Wainwright | Buy |
| 2018-12-06 | Iniziato | ROTH Capital | Buy |
| 2017-09-25 | Reiterato | H.C. Wainwright | Buy |
| 2017-08-10 | Reiterato | Rodman & Renshaw | Buy |
| 2017-05-05 | Reiterato | Rodman & Renshaw | Buy |
| 2016-11-11 | Reiterato | FBR & Co. | Outperform |
| 2016-03-17 | Reiterato | FBR Capital | Outperform |
| 2016-03-03 | Iniziato | FBR Capital | Outperform |
| 2015-11-16 | Reiterato | ROTH Capital | Neutral |
| 2015-10-29 | Reiterato | ROTH Capital | Neutral |
| 2015-05-06 | Downgrade | ROTH Capital | Buy → Neutral |
| 2014-12-08 | Reiterato | ROTH Capital | Buy |
| 2011-10-03 | Downgrade | Maxim Group | Buy → Hold |
Mostra tutto
CorMedix Inc Borsa (CRMD) Ultime notizie
CorMedix Buyback And Melinta Integration Reframe Anti Infectives Growth Story - Yahoo Finance
Aug Wrap: What makes CorMedix Inc stock attractive todayMarket Sentiment Summary & Capital Protection Trade Alerts - baoquankhu1.vn
CorMedix to Participate in Upcoming Investor Conferences - GlobeNewswire
CorMedix Inc. (CRMD) board approves multi-year $75M stock buyback - MSN
CorMedix Inc. (CRMD) Board Approves Multi-Year $75M Stock Buyback - Insider Monkey
Citizens reiterates Market Outperform rating on CorMedix stock By Investing.com - Investing.com Canada
Why is CorMedix Inc stock going downWeekly Gains Report & Free Community Supported Trade Ideas - baoquankhu1.vn
CorMedix Banks on DefenCath Sales in Q4 as Melinta Adds Upside - Yahoo Finance
Analyst Expectations For Cormedix's Future - Benzinga
10 Best Long Term Healthcare Stocks to Buy - Insider Monkey
Why CorMedix could be the biopharma name to watch early in 2026 - MSN
Cormedix Inc (CRMD) Live Share Price, Invest From India - INDmoney
EV Market: What makes CorMedix Inc stock attractive todayTrade Exit Summary & Weekly High Conviction Trade Ideas - baoquankhu1.vn
CorMedix Inc. (NASDAQ:CRMD) Not Doing Enough For Some Investors As Its Shares Slump 35% - simplywall.st
CorMedix Inc. (CRMD) Stock Analysis: A Biotech Company with Over 100% Potential Upside - DirectorsTalk Interviews
CorMedix sets $75M stock buyback plan - MSN
CorMedix stock rises after announcing $75 million share buyback plan By Investing.com - Investing.com South Africa
CorMedix stock rises after announcing $75 million share buyback plan - Investing.com
CorMedix announces $75 million share repurchase program By Investing.com - Investing.com Canada
CorMedix Announces $75 Mln Share Buyback Program - Nasdaq
CorMedix Therapeutics Announces Share Repurchase Program - The Manila Times
Setup Watch: Is CorMedix Inc benefiting from interest rate changesAnalyst Downgrade & Reliable Trade Execution Plans - baoquankhu1.vn
Assessing CorMedix (CRMD) Valuation After Recent Share Price Pressure And Long Term Gains - Yahoo Finance
CorMedix Analyst Day To Clarify REZZAYO And DefenCath Phase III Path - Yahoo Finance
H.C. Wainwright Signal Clinical Data to Drive CorMedix Inc. (CRMD) Future Over Commercial Performance - Finviz
CorMedix Inc. (CRMD) Stock Analysis: Exploring an 85% Potential Upside with Strong Buy Ratings - DirectorsTalk Interviews
CRMD Down 31% in a Month: Is This an Indication to Sell the Stock? - Finviz
Risk Check: Can SPNT expand its profit margins2025 Investor Takeaways & Weekly Watchlist for Consistent Profits - baoquankhu1.vn
What is the long term forecast for CorMedix Inc. stockTrade Performance Summary & Daily Momentum Trading Reports - Mfd.ru
Market Leaders: Will CorMedix Inc benefit from seasonality2025 Performance Recap & Expert Curated Trade Setup Alerts - baoquankhu1.vn
CorMedix Therapeutics to Host In-Person and Virtual Analyst Day in New York on February 10, 2026 - marketscreener.com
Will CRMD's bearish 2026 view impact DefenCath's long-term adoption? - MSN
Published on: 2026-01-26 05:38:56 - baoquankhu1.vn
Is CorMedix (CRMD) A Potential Opportunity After Recent Share Price Volatility? - simplywall.st
H.C. Wainwright Maintains CorMedix(CRMD.US) With Buy Rating, Cuts Target Price to $13 - 富途牛牛
Will CRMD'S Bearish 2026 View Impact DefenCath's Long-Term Adoption? - Yahoo Finance
CorMedix director Dillione sells $68,800 in shares By Investing.com - Investing.com Nigeria
CorMedix director Dillione sells $68,800 in shares - Investing.com
Guidance Update: What is the next catalyst for Pyxis Tankers Inc Equity WarrantWeekly Trade Report & High Return Trade Opportunity Guides - baoquankhu1.vn
Where Cormedix Stands With Analysts - Benzinga
RBC Capital Lowers Price Target for CRMD, Maintains Outperform R - GuruFocus
CorMedix (CRMD) price target decreased by 11.28% to 17.19 - MSN
CorMedix Investors Seek First OK Of Governance Reform Deal - Law360
CorMedix Inc Azioni (CRMD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.64%
0.44%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):